Clinical Trial Update: Autologous Transplant To End NMO Spectrum Disorder [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating autologous transplant for Neuromyelitis Optica spectrum disorders has been withdrawn at Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Devic Disease
• Neuromyelitis Optica
• Nmo Spectrum Disorder

Snippet

Sponsor: Northwestern University | Conditions: Neuromyelitis Optica, Devic's Disease | Phase 2, Phase 3 | Status: WITHDRAWN